Search Results - Richard Dillon

Refine Results
  1. 1
    Criteria for Diagnosis and Molecular Monitoring of <i>NPM1</i>-Mutated AML

    Criteria for Diagnosis and Molecular Monitoring of <i>NPM1</i>-Mutated AML by Brunangelo Falini, Richard Dillon

    Published 2023
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML) by Richard Dillon, Nicola Potter, Sylvie D. Freeman, Nigel H. Russell

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

    Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial by Nigel H. Russell, Alan K. Burnett, Robert K. Hills, Sophie Betteridge, Mike Dennis, Jelena Jovanović, Richard Dillon, David Grimwade

    Published 2018
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  4. 4
    Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis

    Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis by Aileen Rowan, Richard Dillon, Aviva Witkover, Anat Melamed, Maria-Antonietta Demontis, Nicolas Gillet, Liew Jun Mun, Charles R. M. Bangham, Lucy Cook, Paul Fields, Graham P. Taylor

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without <i>NPM1</i> Mutations

    Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without <i>NPM1</i> Mutations by Sylvie D. Freeman, Robert K. Hills, Paul Virgo, Naeem Khan, Steve Couzens, Richard Dillon, Amanda Gilkes, Laura Upton, Ove Juul Nielsen, James D. Cavenagh, Gail Jones, Asim Khwaja, Paul Cahalin, Ian Thomas, David Grimwade, Alan K. Burnett, Nigel H. Russell

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Venetoclax induces rapid elimination of <i>NPM1</i> mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia

    Venetoclax induces rapid elimination of <i>NPM1</i> mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia by Ing Soo Tiong, Richard Dillon, Adam Ivey, Tse‐Chieh Teh, Phillip Nguyen, Nicholas J. Cummings, David Taussig, Annie‐Louise Latif, Nicola Potter, Manohursingh Runglall, Nigel H. Russell, Kavita Raj, Anthony P. Schwarer, Chun Yew Fong, Andrew Grigg, Andrew H. Wei

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

    Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS by Justin Loke, Nicholas McCarthy, Aimee Jackson, Shamyla Siddique, Andrea Hodgkinson, John Hope Mason, Charles Crawley, Maria Gilleece, Andrew Peniket, Rachel Protheroe, Rahuman Salim, Eleni Tholouli, Keith M. O. Wilson, Georgia Andrew, Richard Dillon, Naeem Khan, Victoria Potter, Pramila Krishnamurthy, Charles Craddock, Sylvie D. Freeman

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

    Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome by Sun Loo, Richard Dillon, Adam Ivey, Natasha S. Anstee, Jad Othman, Ing Soo Tiong, Nicola Potter, Jelena Jovanović, Manohursingh Runglall, Chyn Chua Chong, Ashish Bajel, David Ritchie, Kelli Gray, Zhi Han Yeoh, Michelle McBean, Amanda Gilkes, Ian Thomas, Sean Johnson, Nigel H. Russell, Andrew H. Wei

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

    Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC) by Ing Soo Tiong, Devendra Hiwase, Emad Uddin Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S. Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn Wiltshire, Shaun Fleming, Chun Yew Fong, Tse‐Chieh Teh, Piers Blombery, Richard Dillon, Adam Ivey, Andrew H. Wei

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

    Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neop... by Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto‐García, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Donal P. McLornan

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Clinical impact of <i>NPM1</i>-mutant molecular persistence after chemotherapy for acute myeloid leukemia

    Clinical impact of <i>NPM1</i>-mutant molecular persistence after chemotherapy for acute myeloid leukemia by Ing Soo Tiong, Richard Dillon, Adam Ivey, James A. Kuzich, Nisha Thiagarajah, Kirsty Sharplin, Chung Hoow Kok, Aditya Tedjaseputra, James Rowland, Carolyn Grove, Emad Uddin Abro, Jake Shortt, Devendra Hiwase, Ashish Bajel, Nicola Potter, Matthew L Smith, Claire Hemmaway, Abin Thomas, Amanda Gilkes, Nigel H. Russell, Andrew H. Wei

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial

    A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial by Jad Othman, Charlotte S. Wilhelm-Benartzi, Richard Dillon, Steven Knapper, Sylvie D. Freeman, Leona Batten, Joanna Canham, Emily Laura Hinson, Julie Wych, Sophie Betteridge, William Villiers, Michelle Kleeman, Amanda Gilkes, Nicola Potter, Ulrik Malthe Overgaard, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Mike Dennis, Nigel H. Russell

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia

    Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia by Andrea Kühnl, Peter J.M. Valk, Mathijs A. Sanders, Adam Ivey, Robert K. Hills, Ken Mills, Rosemary E. Gale, Martin Kaiser, Richard Dillon, Melanie Joannides, Amanda Gilkes, Torsten Haferlach, Susanne Schnittger, Estelle Duprez, David C. Linch, Ruud Delwel, Bob Löwenberg, Claudia D. Baldus, Ellen Solomon, Alan K. Burnett, David Grimwade

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia

    Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patie... by Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal P. McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto‐García, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Hugues de Lavallade

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

    T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy by Claire Horgan, Khushnuma Mullanfiroze, Archana Rauthan, Katharine Patrick, Naeem Akram Butt, Oana Mirci‐Danicar, Olya O’Connor, Caroline L. Furness, Akshay Deshpande, Sarah Lawson, Valerie Broderick, Pamela Evans, Brenda Gibson, Wing Roberts, Salah Ali, Sevasti Galani, Amy A. Kirkwood, Jelena Jovanović, Richard Dillon, Paul Virgo, Beki James, Kanchan Rao, Persis Amrolia, Robert Wynn

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

    Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML by Faisal Basheer, George Giotopoulos, Eshwar Meduri, Haiyang Yun, Milena Mazan, Daniel Sasca, Paolo Gallipoli, Ludovica Marando, Malgorzata Gozdecka, Ryan Asby, Olivia Sheppard, Monika Dudek, Lars Bullinger, Hartmut Döhner, Richard Dillon, Sylvie D. Freeman, Oliver G. Ottmann, Alan K. Burnett, Nigel H. Russell, Elli Papaemmanuil, Robert K. Hills, Peter J. Campbell, George S. Vassiliou, Brian J.P. Huntly

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

    Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia by Charles Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiří Pavlů, Jenny Byrne, Richard Dillon, Naeem Khan, Nicholas McCarthy, Sylvie D. Freeman

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Unified classification and risk-stratification in Acute Myeloid Leukemia

    Unified classification and risk-stratification in Acute Myeloid Leukemia by Yanis Tazi, Juan E. Arango‐Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie D. Freeman, Yoann Pradat, Sean Johnson, Robert K. Hills, Richard Dillon, Max F. Levine, Daniel Leongamornlert, Adam P. Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver G. Ottmann, Richard Adams, Hartmut Döhner, Peter J. Campbell, Alan K. Burnett, Michael Dennis, Nigel H. Russell, Sean M. Devlin, Brian J.P. Huntly, Elli Papaemmanuil

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Overlapping features of therapy-related and de novo <i>NPM1</i>-mutated AML

    Overlapping features of therapy-related and de novo <i>NPM1</i>-mutated AML by Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F. Schlenk, Richard Dillon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Éric Delabesse, Pierre‐Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Gilkes, Ian Thomas, Maria Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjørn Tore Gjertsen, Maria Paola Martelli, Christian Récher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Müller‐Tidow, Claudia D. Baldus, T. Haferlach, Nigel H. Russell, Brunangelo Falini

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia

    Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia by César Alexander Ortiz Rojas, Diego A. Pereira‐Martins, Isabel Weinhäuser, Luciana Yamamoto Almeida, Thiago Mantello Bianco, Lorena Lobo Figueiredo‐Pontes, Luisa C A Koury, Raul Antônio Morais Melo, Rosane Bittencourt, Kátia Bórgia Barbosa Pagnano, Ricardo Pasqüini, Elenaide C. Nunes, Evandro M. Fagundes, Ana Glória, Fábio R. Kerbauy, Armand Keating, Martin S. Tallman, Raul C. Ribeiro, Richard Dillon, Arnold Ganser, Bob Löwenberg, Peter J.M. Valk, Miguel Á. Sanz, Nancy Berliner, Eduardo Magalhães Rego

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: